To further address which marker is the best to identify NSCLC TICs, we performed a side-by-side comparison of the tumorigenic potential among α2δ1+, CD133+, and CD166+ A549 cells in NOD-SCID mice. Here, PROM1 is linked to non-small cell lung carcinoma.